Mitsui Chemicals stock gets a new life sciences catalyst

Published on 10/07/2026 at 06:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mitsui Chemicals stock traded at JPY 2,179.50 on October 7, 2026, up 0.32 percent in Tokyo. Latest-quarter net income reached JPY 32.093 billion.

Mitsui Chemicals, JP3888300005, Illustration mit AI erstellt.

Mitsui Chemicals stock (JP3888300005) was trading at JPY 2,179.50 on the Tokyo Stock Exchange on October 7, 2026, up 0.32 percent from the previous close. The company has added a life sciences product to its portfolio with the launch of InnoCell P-Type, a culture plate designed for organoid and three-dimensional cell research.

InnoCell targets drug discovery

According to WebWire on October 6, 2026, Mitsui Chemicals launched InnoCell P-Type on October 1, 2026. The plate combines high oxygen permeability with surface treatment, low autofluorescence and low drug adsorption, a feature set aimed at organoid culture, efficacy testing and high-throughput screening.

The product launch gives the Life and Healthcare Solutions segment a concrete technology angle beyond the group's larger materials operations. Testing cited by the company involved cardiac organoids at Kansai Medical University and intestinal organoid-derived epithelial cells at the University of Michigan Medical School, with the evaluations pointing to more uniform tissue formation and lower variability than conventional setups.

Quarterly profit supplies the comparison

The latest quarter reported on August 5, 2026, produced revenue of JPY 460.046 billion and net income of JPY 32.093 billion, according to Investing.com. Revenue increased 2.22 percent from JPY 450.043 billion in the previous quarter, while net income rose 172.04 percent from JPY 11.797 billion.

The earnings mix matters because the product announcement is arriving alongside a measurable profit recovery. Mitsui Chemicals also reported latest-quarter earnings per share of JPY 88.78, compared with a published estimate of JPY 13.28, while revenue of JPY 460.05 billion exceeded the listed estimate of JPY 440.8 billion.

Analysts see further valuation room

MarketScreener lists an Outperform consensus from 11 analysts, with an average target price of JPY 2,498.18. That target lies 14.62 percent above the JPY 2,179.50 reference price, although the consensus is separate from the company's reported results and does not guarantee a future return.

The market picture is therefore balanced between a near-term product catalyst and evidence from the latest quarter. At JPY 2,179.50, the stock stood below its JPY 2,477.50 52-week high and above its JPY 1,737.00 low on October 7, 2026.

Mitsui Chemicals stock holds near JPY 2,180

Mitsui Chemicals stock was last at JPY 2,179.50 on the Tokyo Stock Exchange at 1:10 p.m. JST on October 7, 2026. Its market capitalization was JPY 802.3 billion at that time.